Maxcyte (MXCT) Interest & Investment Income (2020 - 2026)
Maxcyte (MXCT) posted quarterly Interest & Investment Income of $1.4 million for Q1 2026, down 29.45% year-over-year from $2.0 million in Q1 2025, and down 11.96% quarter-over-quarter from $1.6 million in Q4 2025.
Maxcyte (MXCT) Interest & Investment Income (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Interest & Investment Income for 7 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income fell 29.45% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $6.7 million (down 29.27% YoY), while the FY2025 annual figure was $7.3 million, down 28.35% from the prior year.
- Interest & Investment Income eased to $1.4 million in Q1 2026 per MXCT's latest filing, from $1.6 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.8 million in Q4 2023 and bottomed at $91800.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $1.9 million across 5 years, with a median of $2.0 million in 2025.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 5466.28% — and 2025, when it sank 30.57%.
- Maxcyte's Interest & Investment Income stood at $2.0 million in 2022, then jumped by 44.36% to $2.8 million in 2023, then fell by 18.24% to $2.3 million in 2024, then dropped by 29.25% to $1.6 million in 2025, then retreated by 11.96% to $1.4 million in 2026.
- Business Quant data shows MXCT's Interest & Investment Income at $1.4 million in Q1 2026, $1.6 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | - |
| 10 | Maxcyte | 148.48 Mn | 148.48 Mn | 5.60 Mn | 1.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36 Mn |
| Mar 31, 2026 | 1.44 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 2.03 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 2.59 Mn |
| Mar 31, 2024 | 2.75 Mn |
| Dec 31, 2023 | 2.82 Mn |
| Sep 30, 2023 | 2.70 Mn |
| Jun 30, 2023 | 2.56 Mn |
| Mar 31, 2023 | 2.30 Mn |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | 1.39 Mn |
| Jun 30, 2022 | 478,700.00 |
| Mar 31, 2022 | 91,800.00 |
| Dec 31, 2021 | 80,800.00 |
| Sep 30, 2021 | 51,500.00 |